Literature DB >> 22777415

Development of a formula to predict parathyroid carcinoma in patients with primary hyperparathyroidism.

Elias Karakas1, Hans-Helge Müller, Vladimir K Lyadov, Stephanie Luz, Ralph Schneider, Matthias Rothmund, Detlef K Bartsch, Katja Schlosser.   

Abstract

BACKGROUND: Cure of parathyroid carcinoma (PC) requires initial en bloc resection, including resection of all tumor-bearing tissue, with hemithyroidectomy and dissection of the central lymph node compartment. Unfortunately, no reliable preoperative criteria have yet been assessed to indicate a high likelihood of PC. Thus, the aim of the present study was to develop a formula to indicate preoperatively the presence of PC.
METHODS: A prospective database of 1,363 patients with primary hyperparathyroidism (pHPT) was screened for patients with PC. Age, gender, surgical procedures, laboratory data, and follow-up results were evaluated and compared to a group of patients with benign pHPT. Based on preoperative serum calcium (Ca) and parathyroid hormone (PTH) levels, as well as patients' age at the time of diagnosis, a formula was developed by a multivariate logistic model that estimates the individual risk for PC.
RESULTS: Between 1987 and 2008, 19 patients with PC were identified. Ca (3.8 ± 0.3 vs 2.9 ± 0.3 mmo/l; p = 0.0002) and PTH levels (1,250 ± 769 vs 194 ± 204 pg/ml; p = 0.0030) were significantly higher in patients with PC than in those with benign pHPT. Patients with PC were also significantly younger than patients with benign pHPT (48.9 ± 12.1 vs 59.1 ± 13.8 years; p < 0.05). With a ≥5 % probability that a given patient suffered from PC, the sensitivity and specificity to identify the disease were 100 and 30 %, respectively, with the new Ca, PTH, and age based logarithmic formula.
CONCLUSIONS: The new logarithmic formula can be used to calculate the individual risk for PC. If the calculated individual risk exceeds 5 %, en bloc resection seems to be justified to provide long-term cure in case of PC.

Entities:  

Mesh:

Year:  2012        PMID: 22777415     DOI: 10.1007/s00268-012-1707-9

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  37 in total

1.  Surgical treatment of ten cases of parathyroid carcinoma: importance of an initial en bloc tumor resection.

Authors:  Y Fujimoto; T Obara; Y Ito; K Kanazawa; Y Aiyoshi; M Nobori
Journal:  World J Surg       Date:  1984-06       Impact factor: 3.352

2.  Metastatic nonfunctioning parathyroid carcinoma: ultrastructural evidence of secretory granules and response to chemotherapy.

Authors:  A P Chahinian; J F Holland; H E Nieburgs; A Marinescu; S A Geller; P A Kirschner
Journal:  Am J Med Sci       Date:  1981 Sep-Oct       Impact factor: 2.378

Review 3.  Primary hyperparathyroidism: can parathyroid carcinoma be anticipated on clinical and biochemical grounds? Report of nine cases and review of the literature.

Authors:  John H Robert; Andrea Trombetti; Alain Garcia; Jean-Claude Pache; François Herrmann; Anastase Spiliopoulos; René Rizzoli
Journal:  Ann Surg Oncol       Date:  2005-05-05       Impact factor: 5.344

4.  Hormonal and biochemical normalization and tumor shrinkage induced by anti-parathyroid hormone immunotherapy in a patient with metastatic parathyroid carcinoma.

Authors:  D Betea; A R Bradwell; T C Harvey; G P Mead; H Schmidt-Gayk; B Ghaye; A F Daly; A Beckers
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

5.  Parathyroid carcinoma: features and difficulties in diagnosis and management.

Authors:  B J Anderson; N A Samaan; R Vassilopoulou-Sellin; N G Ordonez; R C Hickey
Journal:  Surgery       Date:  1983-12       Impact factor: 3.982

Review 6.  Diagnosis and treatment of patients with parathyroid carcinoma: an update and review.

Authors:  T Obara; Y Fujimoto
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

Review 7.  Parathyroid carcinoma: clinical and pathologic features in 43 patients.

Authors:  A G Wynne; J van Heerden; J A Carney; L A Fitzpatrick
Journal:  Medicine (Baltimore)       Date:  1992-07       Impact factor: 1.889

Review 8.  Parathyroid carcinoma.

Authors:  E Kebebew
Journal:  Curr Treat Options Oncol       Date:  2001-08

9.  Prognostic factors in parathyroid cancer: a review of 95 cases.

Authors:  K Sandelin; G Auer; L Bondeson; L Grimelius; L O Farnebo
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

10.  Metastatic parathyroid carcinoma: dilemmas in management.

Authors:  K Sandelin; N W Thompson; L Bondeson
Journal:  Surgery       Date:  1991-12       Impact factor: 3.982

View more
  6 in total

1.  Immunohistochemical Expression of E-Cadherin in Atypical Parathyroid Adenoma.

Authors:  Ralph Schneider; Stefanie Bartsch-Herzog; Annette Ramaswamy; Detlef K Bartsch; Elias Karakas
Journal:  World J Surg       Date:  2015-10       Impact factor: 3.352

2.  [Surgical treatment of parathyroid carcinoma : Does the initial en bloc resection improve the prognosis?]

Authors:  S Wächter; K Holzer; J Manoharan; C Brehm; I Mintziras; D K Bartsch; E Maurer
Journal:  Chirurg       Date:  2019-11       Impact factor: 0.955

3.  Parafibromin, galectin-3, PGP9.5, Ki67, and cyclin D1: using an immunohistochemical panel to aid in the diagnosis of parathyroid cancer.

Authors:  Peter P Truran; Sarah J Johnson; Richard D Bliss; Thomas W J Lennard; Sebastian R Aspinall
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

4.  [Diagnostics and treatment of primary hyperparathyroidism].

Authors:  C Nies
Journal:  Chirurg       Date:  2017-12       Impact factor: 0.955

5.  Fine-needle aspiration cytology of parathyroid carcinoma mimic hürthle cell thyroid neoplasm.

Authors:  Chutintorn Sriphrapradang; Pattana Sornmayura; Niramol Chanplakorn; Objoon Trachoo; Pattarana Sae-Chew; Rangsima Aroonroch
Journal:  Case Rep Endocrinol       Date:  2014-08-10

6.  Evaluation of malignant parathyroid tumours in two European cohorts of patients with sporadic primary hyperparathyroidism.

Authors:  Arturs Ozolins; Zenons Narbuts; Andrejs Vanags; Zane Simtniece; Zane Visnevska; Aycan Akca; Denis Wirowski; Janis Gardovskis; Ilze Strumfa; Peter E Goretzki
Journal:  Langenbecks Arch Surg       Date:  2015-12-11       Impact factor: 3.445

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.